Terumo Neuro has launched the Sofia Flow 88 large-bore aspiration catheter, designed for supporting clot removal in stroke ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia Flow 88 ...

BioArctic AB (publ) today welcomes investors, analysts and financial media to the company's Capital Markets Day. The event, which starts at 10:30 CET, will be broadcast live online. Over the past 20 ...

Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19 ...

The market is poised for significant growth, with projections estimating a market value of around $32 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of approximately 6.0% duri ...

Access Terumo Corp. stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily. Investing.com - Financial Markets Worldwide ...

The FDA has granted fast-track designation to an investigational antisense oligonucleotide that targets a specific driver of axonal degeneration in those with ALS, according to the manufacturer ...

Dr Cheryl Barton discusses the recent developments in neuroplastogens and how they may offer a new approach to treating neurological diseases. Neurological diseases such as treatment-resistant ...